UNIVERSAL BIOSENSORS INC. — Director's Dealing 2025

Jan 16, 2025

Appendix 3X Initial Director’s Interest Notice

Rule 3.19A.1

Appendix 3X

Initial Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity: Universal Biosensors, Inc.

ARBN: 121 559 993

We (the entity) give ASX the following information under listing rule 3.19A.1 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	John Sharman
Date of appointment	15 January 2025

Part 1 - Director’s relevant interests in securities of which the director is the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Number & class of securities

103,055 CDIs (equivalent to 103,055 fully paid ordinary shares).

3,750,000 performance rights with an expiry date of 24 March 2025 and nil exercise price.

2,364,667 unquoted options with an expiry date of 24 March 2025 and an exercise price of $0.25 per option.

1,364,667 unquoted options with an expiry date of 24 March 2025 and an exercise price of $0.30 per option.

23,055 quoted options with an expiry date of 8 May 2027 and an exercise price of $0.20 per option.

Part 2 – Director’s relevant interests in securities of which the director is not the

registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

• See chapter 19 for defined terms.

11/3/2002

Appendix 3X Page 1

Appendix 3X Initial Director’s Interest Notice

Name of holder & nature of interest Note: Provide details of the circumstances giving rise to the relevant interest. J S Super Fund (John Sharman is the trustee and beneficiary) Amira Sharman (spouse)

Number & class of Securities 394,666 CDIs (equivalent to 394,666 fully paid ordinary shares). 1,000,000 unquoted options with an expiry date of 24 March 2025 and an exercise price of $0.30 per option. 30,000 quoted options with an expiry date of 8 May 2027 and an exercise price of $0.20 per option. 1,561,217 CDIs (equivalent to 1,561,217 fully paid ordinary shares). 10,000 quoted options with an expiry date of 8 May 2027 and an exercise price of $0.20 per option.

Part 3 – Director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	Nil
Nature of interest
Name of registered holder (if issued securities)
No. and class of securities to which interest relates

• See chapter 19 for defined terms.

Appendix 3X Page 2

11/3/2002